Efficacy, safety and tolerability of tofacitinib in patients with an inadequate response to disease modifying anti-rheumatic drugs: a meta-analysis of randomized double-blind controlled studies

BACKGROUND: This meta-analysis was conducted to determine the efficacy, safety and tolerability of tofacitinib in the treatment of rheumatoid arthritis in patients with an inadequate response or intolerance to at least one of the nonbiologic or biologic disease-modifying antirheumatic drugs (DMARDs)...

Descripción completa

Detalles Bibliográficos
Autor principal: Berhan, Asres
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4222887/
https://www.ncbi.nlm.nih.gov/pubmed/24279308
http://dx.doi.org/10.1186/1471-2474-14-332

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4222887/
https://www.ncbi.nlm.nih.gov/pubmed/24279308
http://dx.doi.org/10.1186/1471-2474-14-332

Ejemplares similares